Abstract

Short Communication

Optimizing Treatment of Depression, Trauma, and Anxiety Disorders through Neurophysiological Interventions

Kees Blasé*

Published: 15 October, 2025 | Volume 9 - Issue 1 | Pages: 027-029

Depression, trauma, and anxiety disorders continue to be predominant causes of global disability, with typical therapies proving to be only marginally successful. Heart Rate Variability Biofeedback (HRVB) offers patients a self-regulation method that improves the flexibility of the autonomic nerve system via resonance breathing. Clinical research shows that training can significantly lower symptoms of sadness and PTSD, with improvements shown after 4 to 8 weeks. HRVB is inexpensive, non-invasive, and scalable, making it a promising supplementary therapy in psychiatry. Subsequent study ought to inform its incorporation into clinical protocols.

Read Full Article HTML DOI: 10.29328/journal.ida.1001046 Cite this Article Read Full Article PDF

Keywords:

Self-control; HRV; HRVBiofeedback; PTSD; Depression; Anxiety; Vagal nerve; Psychophysiology

References

  1. World Health Organization (WHO). Depression and anxiety fact sheet. Geneva: WHO; 2023 [cited 2025 Oct 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
  2. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93(5):1043–65. Available from: https://pubmed.ncbi.nlm.nih.gov/8598068/
  3. Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability: clinical consequences and implications for treatment. Psychiatry Res. 2002;113(1–2):139–49. Available from: https://doi.org/10.1016/s0165-1781(02)00225-1
  4. Karavidas MK. Heart rate variability biofeedback for major depression. Biofeedback. 2008;36:18–21. Available from: https://www.researchgate.net/publication/242455597_Heart_Rate_Variability_Biofeedback_for_Major_Depression
  5. Sloan RP, Shapiro PA, Bagiella E, Kuhl JP, Steinman RC, Gorman JM. Cardiac autonomic control and treatment of hostility: a randomized controlled trial. Psychosom Med. 2010;72(1):1–8. Available from: https://doi.org/10.1097/PSY.0b013e3181c8a529
  6. Lin IM, Fan SY, Yen CF, Yeh YC, Tang TC, Huang MF, et al. HRV biofeedback increased autonomic activation and improved symptoms of depression and insomnia in major depressive disorder. Clin Psychopharmacol Neurosci. 2019;17(2):222–32. Available from: https://doi.org/10.9758/cpn.2019.17.2.222
  7. Porges SW. The polyvagal theory: neurophysiological foundations of emotions, attachment, communication, and self-regulation. New York: W.W. Norton; 2011. Available from: https://www.scirp.org/reference/referencespapers?referenceid=1683048
  8. Gevirtz R. The promise of heart rate variability biofeedback: evidence-based applications. Biofeedback. 2013;41(3):110–20. Available from: https://doi.org/10.5298/1081-5937-41.3.01
  9. Blase KL, van Dijke A, Cluitmans PJ, Vermetten E. Effectiveness of HRV biofeedback in depression and PTSD. Tijdschr Psychiatr. 2016;58(4):292–300. Available from: https://pubmed.ncbi.nlm.nih.gov/27075221/
  10. Blase K, Vermetten E, Lehrer P, Gevirtz R. Neurophysiological approach by self-control of the ANS in depression, stress, and anxiety. Int J Environ Res Public Health. 2021;18(7):3329. Available from: https://doi.org/10.3390/ijerph18073329
  11. Lehrer PM, Gevirtz R, Simeon D, Shah K, Huseby R, Bhavsar J, et al. Heart rate variability biofeedback in psychiatric disorders: evidence and future directions. Appl Psychophysiol Biofeedback. 2020;45(3):207–22. Available from: https://doi.org/10.1007/s10484-020-09466-z
  12. Goessl VC, Curtiss JE, Hofmann SG. The effect of HRV biofeedback on stress and anxiety: a meta-analysis. Psychol Med. 2017;47(15):2578–86. Available from: https://doi.org/10.1017/s0033291717001003
  13. van der Kolk B. Clinical implications of neuroscience research in PTSD. Ann N Y Acad Sci. 2006;1071:277–93. Available from: https://doi.org/10.1196/annals.1364.022
  14. Siepmann M, Aykac V, Unterdörfer J, Petrowski K, Mueck-Weymann M. A pilot study on the effects of HRV biofeedback in patients with depression and PTSD. Appl Psychophysiol Biofeedback. 2008;33(4):195–201. Available from: https://doi.org/10.1007/s10484-008-9064-z

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

  • Breast Imaging Services Utilization Trends Across Private and Government-Insured Patients in a National Radiology Practice
    Andrew K Hillman*, Phil Ramis, Patrick Nielsen, Sophia N Swanston, Dana Bonaminio and Eric M Rohren Andrew K Hillman*,Phil Ramis,Patrick Nielsen,Sophia N Swanston,Dana Bonaminio,Eric M Rohren. Breast Imaging Services Utilization Trends Across Private and Government-Insured Patients in a National Radiology Practice. J Clin Med Exp Images. 2025: doi: 10.29328/journal.jcmei.1001037; 9: 020-027
  • The Bacteriological Profile of Nosocomial Infections at the Army Central Hospital of Brazzaville
    Medard Amona*, Yolande Voumbo Matoumona Mavoungou, Hama Nemet Ondzotto, Benjamin Kokolo, Armel Itoua, Gilius Axel Aloumba and Pascal Ibata Medard Amona*,Yolande Voumbo Matoumona Mavoungou,Hama Nemet Ondzotto,Benjamin Kokolo,Armel Itoua,Gilius Axel Aloumba,Pascal Ibata. The Bacteriological Profile of Nosocomial Infections at the Army Central Hospital of Brazzaville. Int J Clin Microbiol Biochem Technol. 2025: doi: 10.29328/journal.ijcmbt.1001032; 8: 009-022
  • Individual Treatment Trial of PIGV-Associated Mabry Syndrome with D-Mannose in a Young Child
    Marta Agnes Somorai*, Annabelle Arlt, Peter Krawitz, Jochen Baumkötter and Volker Mall Marta Agnes Somorai*, Annabelle Arlt, Peter Krawitz, Jochen Baumkötter, Volker Mall. Individual Treatment Trial of PIGV-Associated Mabry Syndrome with D-Mannose in a Young Child. J Genet Med Gene Ther. 2023: doi: 10.29328/journal.jgmgt.1001008; 6: 001-004
  • Management and Therapeutic Strategies for Spinal Muscular Atrophy
    Sheena P Kochumon and Cherupally Krishnan Krishnan Nair* Sheena P Kochumon, Cherupally Krishnan Krishnan Nair*. Management and Therapeutic Strategies for Spinal Muscular Atrophy. J Genet Med Gene Ther. 2024: doi: 10.29328/journal.jgmgt.1001009; 7: 001-007
  • Germline BRCA1 Mutation inSquamous Cell Carcinoma of Oesophagus: Driver versus Passenger Mutation
    Amrit Kaur Kaler*, Shraddha Manoj Upadhyay, Nandini Shyamali Bora, Ankita Nikam, Kavya P, Nivetha Athikeri, Dattatray B Solanki, Imran Shaikh and Rajesh Mistry Amrit Kaur Kaler*, Shraddha Manoj Upadhyay, Nandini Shyamali Bora, Ankita Nikam, Kavya P, Nivetha Athikeri, Dattatray B Solanki, Imran Shaikh, Rajesh Mistry. Germline BRCA1 Mutation inSquamous Cell Carcinoma of Oesophagus: Driver versus Passenger Mutation. J Genet Med Gene Ther. 2024: doi: 10.29328/journal.jgmgt.1001011; 7: 015-019

Read More

Most Viewed

Read More

Help ?